ABEO - CIK 0000318306
The table below shows ABEONA THERAPEUTICS INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $61.37M | $82.88M | $163.53M | $15.94M | $15.73M | $34.43M |
| Short-term investments | $106.90M | $124.23M | $61.98M | $68.22M | $93.97M | $88.28M |
| Receivables | $6.20M | - | - | - | - | - |
| Inventory | $6.05M | $4.85M | $2.69M | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $182.99M |
| $216.13M |
| $232.26M |
| $88.12M |
| $112.66M |
| $125.90M |
| Property, plant & equipment | $10.56M | $10.34M | $9.49M | $6.95M | $4.06M | $3.98M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $198.49M | $231.09M | $246.23M | $99.36M | $120.59M | $134.00M |
| Accounts payable | $4.07M | $5.93M | $7.34M | $5.02M | $2.79M | $3.10M |
| Total current liabilities | $31.05M | $22.18M | $34.52M | $17.98M | $18.42M | $16.84M |
| Long-term debt | $4.75M | $10.86M | $14.01M | $11.14M | $14.21M | $16.13M |
| Total liabilities | $53.55M | $59.86M | $82.66M | $57.97M | $74.82M | $60.76M |
| Retained earnings | -$759.15M | -$721.62M | -$716.45M | -$825.29M | -$803.97M | -$773.70M |
| Total equity | $144.94M | $171.23M | $163.58M | $41.40M | $45.77M | $73.24M |